Is NGENF or QYLD a better dividend investment in 2026?

NGENF currently yields 50.63% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: NGENF offers higher current income.

What is the dividend yield difference between NGENF and QYLD?

NGENF has a forward dividend yield of 50.63% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 38.71 percentage points.

Home › Compare › NGENF vs QYLD

NGENF vs QYLD: Dividend Comparison 2026

NGENF yields 50.63% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NGENF wins by $381.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NGENF

● Live price

50.63%

Share price

$3.95

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$407.1K

Annual income

$83,327.27

Full NGENF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — NGENF vs QYLD

📍 NGENF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NGENF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NGENF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NGENF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NGENF

Annual income on $10K today (after 15% tax)

$4,303.80/yr

After 10yr DRIP, annual income (after tax)

$70,828.18/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, NGENF beats the other by $66,017.77/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NGENF + QYLD for your $10,000?

NGENF: 50%QYLD: 50%

100% QYLD50/50100% NGENF

Portfolio after 10yr

$216.2K

Annual income

$44,493.29/yr

Blended yield

20.58%

📊

Analyst Conviction Gap

Where Wall Street is split right now

NGENF

Analyst Ratings

Hold

Consensus: Hold

Altman Z

-3.3

Piotroski

1/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NGENF buys

QYLD buys

No recent congressional trades found for NGENF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNGENFQYLD

Forward yield	50.63% ✓	11.92%
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$407.1K ✓	$25.4K
Annual income after 10y	$83,327.27 ✓	$5,659.31
Total dividends collected	$325.7K ✓	$27.1K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: NGENF vs QYLD ($10,000, DRIP)

Year	NGENF Portfolio	NGENF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$15,763	$5,063.29	$10,352	$1,192.36	+$5.4K → NGENF
2	$24,326	$7,459.26	$10,830	$1,347.57	+$13.5K → NGENF
3	$36,787	$10,758.11	$11,460	$1,539.07	+$25.3K → NGENF
4	$54,567	$15,204.60	$12,275	$1,777.84	+$42.3K → NGENF
5	$79,464	$21,077.77	$13,323	$2,078.95	+$66.1K → NGENF
6	$113,713	$28,686.96	$14,667	$2,463.34	+$99.0K → NGENF
7	$160,039	$38,365.61	$16,396	$2,960.57	+$143.6K → NGENF
8	$221,705	$50,462.91	$18,631	$3,612.97	+$203.1K → NGENF
9	$302,558	$65,333.74	$21,548	$4,482.15	+$281.0K → NGENF
10	$407,064	$83,327.27	$25,398	$5,659.31	+$381.7K → NGENF

NGENF vs QYLD: Complete Analysis 2026

NGENF — Stock

NervGen Pharma Corp., together with its subsidiaries, engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage. Its lead product candidate is NVG-291 that is in phase 1 clinical trial for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. The company has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. NervGen Pharma Corp. was incorporated in 2017 and is based in Vancouver, Canada.

Full NGENF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this NGENF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NGENF vs SCHD NGENF vs JEPI NGENF vs O NGENF vs KO NGENF vs MAIN NGENF vs XYLD NGENF vs JEPQ NGENF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.